| | | Scalable Viral Production Systems | | Accelerate Vaccine Development Timelines |
|
| Dear Reader,
Deliver rapid, accurate, and reproducible results in an efficient and cost-effective manner using our critical solutions for each step of the vaccine development workflow. | | |
|
| | | Alternative Expression Systems for Lentiviral Vector Production in HEK 293T Cells | Lentiviral vectors, used as protein expression systems, are increasingly in demand as candidates for gene and cell therapies and vaccines. Classical two-dimensional culture methods such as multi-layer cell factories, which are used as lentiviral vector production systems, are limited by their poor scalability, high cost, labor intensiveness, and high batch-to-batch variability of production. Most of these problems are diminished using cell culture automation systems like bioreactors.
Read our application note outlining a successful experimental setup to cultivate lentiviral vectors in HEK 293T cells using bioreactors. | | |
|
| | | Free Webinar: Vaccine Development Using Automated Cell Culture Techniques | | | The development and refinement of processes are crucial to establishing cost-efficient workflows in larger volumes. Bioreactors are automation solutions providing safety measures for both the user and samples, risk mitigation benefits, autocalibration of sensors for reproducibility and accountability, and smart software to assist with scaling-up.
In this on-demand webinar, learn how different process parameters can be monitored and controlled using bioreactors and gain expertise on cultivating and growing anchorage-dependent cells on different attachment matrixes for vaccine production. | | |
|
| | Any offers valid in U.S. and Canada only |
| | | | ©2020 Eppendorf North America, Inc. |
|
|
|
|
